If you are not able to view this e-mail properly, please click here to view it online
World Pharma Today Maqazine
World Pharma Today Linkedin Page World Pharma Today Facebook Page World Pharma Today Twitter Page DOWNLOAD
Click here to subscribe to our Magazine
Top Latest Press Releases
Orchard Therapeutics Announces $110M Series

Orchard Therapeutics Announces 110M dollers Series B Financing to Advance Transformative Gene Therapy Pipeline

Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, announced the completion of an oversubscribed ....


NexImmune Raises 23 million doller to advance endogenous cellular immuno therapy into clinical development

NexImmune, an emerging leader in the field of antigen-directed immunotherapy, announced the closing of a Series A financing co-led by new investor ArrowMark Partners and existing investor Barer & Son Capital ...


Adverum biotechnologies doses first patient in the ADVANCE phase 1/2 clinical trial of ADVM-043 for A1AT deficiency

Adverum Biotechnologies, Inc , a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, announced the dosing of the first patient in the ADVANCE Phase ...

Myriad genetics announces expanded research

Myriad genetics announces expanded research collaboration with astra zeneca

Myriad Genetics, Inc. , a leader in molecular diagnostics and personalized medicine, announced that AstraZeneca will use the Company’s myChoice® HRD Plus in an exploratory analysis to identify women with advanced ovarian cancer who may benefit from .....


Clinerion Joins the BlueCloud Network

HealthCarePoint , a Texas-based health care and clinical research networking-technology company founded by patient-survivors, announced its mutual collaboration with Clinerion. The collaboration will further both companies’ shared mission of transforming clinica ...


Organovo receives U.S. FDA for 3D bioprinted therapeutic liver tissue treatment of Alpha-1 Antitrypsin Deficiency

Organovo Holdings, Inc announced that the U.S. FDA granted orphan drug designation for the Company’s treatment of alpha-1 antitrypsin deficiency with ....


For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
call to: + 91 88268 49084

If you like to receive our latest Media Pack 2018 / Editorial Calender please click here

For the latest visit: www.worldpharmatoday.com

World Pharma Today